Resultado de búsqueda
Hace 10 horas · The global companion diagnostics market is projected to reach USD 13.6 billion by 2029 from USD 7.5 billion in 2024, at a CAGR of 12.6% during the forecast period.
Hace 10 horas · Plasma N-terminal prohormone B-type natriuretic peptide (NT-proBNP) concentration is a heart failure (HF) biomarker in adults and children. Its prognostic value for HF-related events has been established only in adults. Therefore, we aimed to test the hypothesis that plasma NT-proBNP concentrations predicted the risk of heart transplantation or death in children with HF. We studied the medical ...
Hace 3 horas · The global companion diagnostics market is projected to reach USD 13.6 billion by 2029 from USD 7.5 billion in 2024, at a CAGR of 12.6% during the forecast period. The report will help market ...
Hace 10 horas · The global geriatric care services market is experiencing a remarkable surge in demand, fueled by a projected Compound Annual Growth Rate (CAGR) of 6.0% from 2022 to 2032. This substantial growth trajectory is expected to propel the market to reach USD 954 Million by 2032, up from USD 534 Million in 2022. This surge in demand underscores an increasing need […]
Hace 3 horas · Mumbai: Alembic Pharmaceuticals Limited announced today that it has received US Food & Drug Administration (USFDA) approvals on five of its products. The company has received five product approvals – three final and two tentative – from 1 st April 2024 till 8 th May 2024.. This includes Diazepam Injection USP, 10 mg/2 mL (5 mg/mL), Single-Dose Prefilled Syringe, Selexipag Tablets 1,000 mcg ...
Hace 1 día · Data from partner Roche from Phase 2 PASADENA clinical trial presented at AD/PD 2024 showed patients with early Parkinson’s ... Total revenue for the first quarter of 2024 was from license fees recognized under a License Agreement with F. Hoffmann-La Roche Ltd. and total revenue for the first quarter of 2023 was primarily ...
Hace 10 horas · Different factors, not limited to the lung, influence the progression of ILDs. A “treatable trait” strategy was recently proposed for ILD patients as a precision model of care to improve outcomes. However, no data have been published so far on the prevalence of TTs in ILD. A prospective, observational, cohort study was conducted within the ILD Program at the IRCCS Humanitas Research ...
